全球醫用吸入一氧化氮市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，醫用吸入一氧化氮市場規模將從 2025 年的 11.4 億美元成長至 22.8 億美元，2026 年至 2034 年的複合年成長率為 7.97%。

受呼吸系統疾病治療中吸入型一氧化氮需求不斷成長的推動，全球醫用吸入型一氧化氮市場呈現穩定成長態勢。吸入型一氧化氮廣泛用於治療新生兒缺氧性呼吸衰竭和肺動脈高壓。呼吸系統疾病盛行率的上升也促進了市場擴張。

關鍵成長要素包括管理系統的進步和加護病房對呼吸治療的日益重視。醫療服務提供者致力於透過標靶治療改善患者預後。人們對專業呼吸照護的認知不斷提高，進一步推動了市場需求。此外，新生兒護理設施的擴建也促進了市場成長。

展望未來，攜帶式給藥設備的技術進步預計將對市場產生正面影響。新興市場對先進醫療基礎設施的投資將創造新的機會。各公司正致力於提高生產成本效益並確保符合監管要求。隨著全球呼吸照護的進步，全球醫用吸入一氧化氮市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球醫用吸入一氧化氮市場：依產品類型分類

• 市場分析、洞察與預測
• 一氧化氮吸入供應系統
• 一氧化氮感測器和監測器

第5章 全球醫用吸入一氧化氮市場：依給藥途徑分類

• 市場分析、洞察與預測
• 吸入用一氧化氮氣體
• 使用氧氣混合氣體吸入一氧化氮

第6章 全球醫用吸入一氧化氮市場：依應用領域分類

• 市場分析、洞察與預測
• 心血管疾病
• 呼吸系統疾病

第7章 全球醫用吸入一氧化氮市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診所

第8章 全球醫用吸入一氧化氮市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bellerophon Therapeutics
  • Praxair Technology Inc.（Linde Plc）
  • Mallinckrodt Pharmaceuticals
  • GE Healthcare
  • Mitsubishi Tanabe Pharma Corporation
  • Vero Biotech LLC
  • Messer Group
  • Air Liquide
  • Nu-Med Plus
  • Beyond Air Inc
  • Others

The Medical Inhaled Nitric Oxide Market size is expected to reach USD 2.28 Billion in 2034 from USD 1.14 Billion (2025) growing at a CAGR of 7.97% during 2026-2034.

The Global Medical Inhaled Nitric Oxide Market is witnessing steady growth driven by increasing use in treating respiratory conditions. Inhaled nitric oxide is commonly used for neonatal hypoxic respiratory failure and pulmonary hypertension. Growing prevalence of respiratory disorders is supporting market expansion.

Key growth drivers include advancements in delivery systems and increasing adoption in intensive care units. Healthcare providers are focusing on improving patient outcomes through targeted therapies. Rising awareness about specialized respiratory treatments is further boosting demand. Additionally, expanding neonatal care facilities are contributing to market growth.

Looking ahead, the market is expected to benefit from technological improvements in portable delivery devices. Emerging markets investing in advanced healthcare infrastructure will create new opportunities. Companies are focusing on cost-effective production and regulatory compliance. As respiratory care advances globally, the Global Medical Inhaled Nitric Oxide Market is projected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Inhaled Nitric Oxide Delivery Systems
• Nitric Oxide Sensors And Monitors

By Route Of Administration

• Inhaled Nitric Oxide Gas
• Inhaled Nitric Oxide With Oxygen Mixtures

By Application

• Cardiovascular Disorders
• Respiratory Disorders

By End User

• Hospitals
• Clinics

COMPANIES PROFILED

• Bellerophon Therapeutics, Praxair Technology Inc Linde plc, Mallinckrodt Pharmaceuticals, GE Healthcare, Mitsubishi Tanabe Pharma Corporation, Vero Biotech LLC, Messer Group, Air Liquide, NuMed Plus, Beyond Air Inc, Others
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and Kilo Tons)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Inhaled Nitric Oxide Delivery Systems Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 4.3. Nitric Oxide Sensors And Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 5. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN and Kilo Tons)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Inhaled Nitric Oxide Gas Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 5.3. Inhaled Nitric Oxide With Oxygen Mixtures Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 6. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY APPLICATION 2022-2034 (USD MN and Kilo Tons)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 6.3. Respiratory Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 7. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY END USER 2022-2034 (USD MN and Kilo Tons)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 7.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 8. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY REGION 2022-2034(USD MN and Kilo Tons)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.2.1 By Product Type
  • 8.2.2 By Route Of Administration
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.3.1 By Product Type
  • 8.3.2 By Route Of Administration
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.4.1 By Product Type
  • 8.4.2 By Route Of Administration
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.5.1 By Product Type
  • 8.5.2 By Route Of Administration
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.6.1 By Product Type
  • 8.6.2 By Route Of Administration
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MEDICAL INHALED NITRIC OXIDE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Bellerophon Therapeutics
  • 10.2.2 Praxair Technology Inc. (Linde Plc)
  • 10.2.3 Mallinckrodt Pharmaceuticals
  • 10.2.4 GE Healthcare
  • 10.2.5 Mitsubishi Tanabe Pharma Corporation
  • 10.2.6 Vero Biotech LLC
  • 10.2.7 Messer Group
  • 10.2.8 Air Liquide
  • 10.2.9 Nu-Med Plus
  • 10.2.10 Beyond Air Inc
  • 10.2.11 Others